Quest Diagnostics Inc
NYSE:DGX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
123.78
163.89
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Quest Diagnostics Inc
Quest Diagnostics Inc
Net Change in Cash
Quest Diagnostics Inc
Net Change in Cash Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Change in Cash
$621m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
29%
|
CAGR 10-Years
48%
|
|
|
DaVita Inc
NYSE:DVA
|
Net Change in Cash
$613.5m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
|
Chemed Corp
NYSE:CHE
|
Net Change in Cash
$65.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CVS Health Corp
NYSE:CVS
|
Net Change in Cash
-$6.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
30%
|
CAGR 10-Years
-33%
|
|
|
Cigna Corp
NYSE:CI
|
Net Change in Cash
-$1.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
41%
|
CAGR 10-Years
1%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Change in Cash
$789.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
7%
|
|
Quest Diagnostics Inc
Glance View
Quest Diagnostics Inc. is a leading provider of diagnostic testing and information services, playing a crucial role in the healthcare ecosystem. With a legacy dating back to the 1960s, Quest has established itself as a trusted partner for healthcare providers by offering a wide range of testing services, including routine blood tests, genetic testing, and specialized diagnostics for chronic diseases. The company's innovative approach to testing, bolstered by its extensive network of laboratories and state-of-the-art technology, ensures accurate and timely results, empowering patients and physicians alike to make informed healthcare decisions. As an industry leader, Quest not only aids in clinical decision-making but also plays a pivotal role in the ongoing shift toward value-based care, which emphasizes quality over quantity in patient treatment. For investors, Quest Diagnostics represents an attractive opportunity due to its strong financial performance and growth potential. The company benefits from a robust demand for diagnostic testing services, especially in the wake of the COVID-19 pandemic, which has heightened awareness of the importance of timely medical diagnostics. Quest's investment in cutting-edge technology and telehealth solutions positions it well to adapt to the evolving healthcare landscape. With a track record of consistent revenue growth and a commitment to returning value to shareholders through dividends and share buybacks, Quest Diagnostics stands out as a solid investment in the healthcare sector, blending stability with innovation in a critical industry.
See Also
What is Quest Diagnostics Inc's Net Change in Cash?
Net Change in Cash
621m
USD
Based on the financial report for Sep 30, 2024, Quest Diagnostics Inc's Net Change in Cash amounts to 621m USD.
What is Quest Diagnostics Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
48%
You don't have any saved screeners yet
